Results 311 to 320 of about 1,287,340 (324)

Two causes of COVID‐19‐related myocardial injury‐associated cardiogenic shock: Myocarditis and microvascular thrombosis

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai   +4 more
wiley   +1 more source

A Non‐Antigenic Randomized Polyethylene Glycol/Poly(2‐Phenyl‐2‐Oxazine)‐Based Drug Delivery Platform

open access: yesMacromolecular Rapid Communications, EarlyView.
Randomized PEG (rPEG), a conceptually new PEG alternative, is combined with poly(2‐phenyl‐2‐oxazine) (PPheOzi) to establish an rPEG‐b‐PPheOzi‐b‐rPEG micellar drug delivery platform. The PPheOzi block enables high drug loadings, while competitive ELISA reveals a drastic reduction in anti‐PEG antibody affinity of rPEG in comparison to PEG.
Julian Schmidt   +6 more
wiley   +1 more source

The Effect of SARS-CoV-2 Reinfection on Long-Term Symptoms in the Innovative Support for Patients With SARS-CoV-2 Infections Registry (INSPIRE). [PDF]

open access: yesClin Infect Dis
Openshaw JJ   +23 more
europepmc   +1 more source

Broadening SARS-CoV-2 Immunity by Combining ORFV and Protein-Based Vaccines. [PDF]

open access: yesVaccines (Basel)
Reguzova A   +4 more
europepmc   +1 more source

Genomic diversity and surveillance of SARS-CoV-2 in Nigeria. [PDF]

open access: yesBMC Genomics
Kono TJY   +18 more
europepmc   +1 more source

Evolution and Viral Properties of the SARS-CoV-2 BA.3.2 Subvariant

open access: yes
Jule Z   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy